Fairman Jeff

VP, Research at PCVX

Sold, on record
$2.9M
Dollars the filings state
Form 4 sales
20
Latest Oct 26, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • PCVXVaxcyte, Inc.VP, Research

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale PCVXPlan not stated
    Mar 11, 2022 2022

    Sold 10,000 shares at $25.50 ($255k)

    Fairman Jeff, VP, Research

    Sold 2.9% of holdings ($8.7M position)331,227 shares left2.1x usual sizeFiling

  2. 2 Form 4 sale PCVXPlan not stated
    Apr 5, 2022 +25 days

    Sold 5,000 shares at $25.59 ($128k)

    Fairman Jeff, VP, Research

    Sold 1.5% of holdings ($8.5M position)326,227 shares left1.1x usual sizeFiling

  3. 3 Form 4 sale PCVXPlan not stated
    May 5, 2022 +30 days

    Sold 888 shares at $25.80 ($23k)

    Fairman Jeff, VP, Research

    Sold 0.3% of holdings ($8.4M position)325,339 shares left0.2x usual sizeFiling

  4. 4 Form 4 sale PCVXPlan not stated
    May 20, 2022 +15 days

    Sold 4,112 shares at $25.50 ($105k)

    Fairman Jeff, VP, Research

    Sold 1.3% of holdings ($8.3M position)321,227 shares left0.9x usual sizeFiling

  5. 5 Form 4 sale PCVXUnusual
    Aug 5, 2022 +77 days

    Sold 15,000 shares at $25.57 ($384k)

    Fairman Jeff, VP, Research

    Sold 4.7% of holdings ($8.2M position)306,227 shares left3.2x usual sizeFiling

  6. 6 Form 4 sale PCVXPlan not stated
    Sep 6, 2022 +32 days

    Sold 5,000 shares at $26.58 ($133k)

    Fairman Jeff, VP, Research

    Sold 1.6% of holdings ($8.1M position)301,227 shares left1.1x usual sizeFiling

  7. 7 Form 4 sale PCVXPlan not stated
    Oct 11, 2022 +35 days

    Sold 5,000 shares at $25.50 ($128k)

    Fairman Jeff, VP, Research

    Sold 1.7% of holdings ($7.7M position)296,227 shares left1.1x usual sizeFiling

  8. 8 Form 4 sale PCVXPlan not stated
    Oct 26, 2022 +15 days

    Sold 10,000 shares at $40.00 ($400k)

    Fairman Jeff, VP, Research

    Sold 3.4% of holdings ($11.8M position)286,227 shares left2.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (20)

Form 144 notices and Form 4 sales by Fairman Jeff
Source
Oct 26, 2022Oct 28, 2022PCVXVP, ResearchForm 4 sale10,000$400k3.4%Plan not statedSEC
Oct 11, 2022Oct 13, 2022PCVXVP, ResearchForm 4 sale5,000$128k1.7%Plan not statedSEC
Sep 6, 2022Sep 7, 2022PCVXVP, ResearchForm 4 sale5,000$133k1.6%Plan not statedSEC
Aug 5, 2022Aug 5, 2022PCVXVP, ResearchForm 4 sale15,000$384k4.7%UnusualSEC
May 20, 2022May 24, 2022PCVXVP, ResearchForm 4 sale4,112$105k1.3%Plan not statedSEC
May 5, 2022May 9, 2022PCVXVP, ResearchForm 4 sale888$23k0.3%Plan not statedSEC
Apr 5, 2022Apr 7, 2022PCVXVP, ResearchForm 4 sale5,000$128k1.5%Plan not statedSEC
Mar 11, 2022Mar 15, 2022PCVXVP, ResearchForm 4 sale10,000$255k2.9%Plan not statedSEC
Dec 27, 2021Dec 28, 2021PCVXVP, ResearchForm 4 sale4,750$112k43.5%UnusualSEC
Dec 16, 2021Dec 20, 2021PCVXVP, ResearchForm 4 sale4,619$104k42.9%UnusualSEC
Dec 9, 2021Dec 13, 2021PCVXVP, ResearchForm 4 sale131$3k2.1%Plan not statedSEC
Oct 26, 2021Oct 28, 2021PCVXVP, ResearchForm 4 sale4,750$108k48.0%UnusualSEC
Sep 27, 2021Sep 29, 2021PCVXVP, ResearchForm 4 sale4,750$124k48.0%UnusualSEC
Aug 26, 2021Aug 30, 2021PCVXVP, ResearchForm 4 sale4,750$121k48.0%UnusualSEC
Jul 26, 2021Jul 28, 2021PCVXVP, ResearchForm 4 sale4,750$108k48.0%UnusualSEC
Jun 28, 2021Jun 30, 2021PCVXVP, ResearchForm 4 sale4,750$116k48.0%UnusualSEC
Jun 7, 2021Jun 9, 2021PCVXVP, ResearchForm 4 sale9,500$214k64.9%UnusualSEC
Mar 26, 2021Mar 29, 2021PCVXVP, ResearchForm 4 sale4,750$113k77.1%UnusualSEC
Feb 26, 2021Mar 2, 2021PCVXVP, ResearchForm 4 sale4,750$114k77.1%UnusualSEC
Jan 26, 2021Jan 28, 2021PCVXVP, ResearchForm 4 sale4,750$120k77.1%UnusualSEC